Jinming Gao, Ph.D., Professor in the Harold C. Simmons Comprehensive Cancer Center and of Biomedical Engineering, Cell Biology, Otolaryngology – Head & Neck Surgery, and Pharmacology at UTSW
UT Southwestern Medical Center scientists have developed a nanoparticle vaccine that successfully eradicated tumors in an animal model of late-stage, metastatic HPV-induced cancers, according to a study published in Proceedings of the National Academy of Sciences (PNAS). The breakthrough could pave the way for a new class of vaccines to treat a variety of cancers.
Jinming Gao, Ph.D., professor at the Harold C. Simmons Comprehensive Cancer Center and of Biomedical Engineering at UT Southwestern states: “Our study provides a safe and effective way to treat cancers that have spread or cannot be surgically removed. Creating a nanovaccine for systemic use for metastatic cancers is not easy due to potential toxicity, but we have overcome those challenges with this new therapy.”
